Wang et al. (2018) also found 45% ANK1 and 45% SPTB mutations. Qin et al. (2020) found ANK1 (46%) and SPTB (46%) mutations in 35 HS patients, while only 9% of patients carried SLC4A1 mutations. Here, ANK1 is linked to histiocytic sarcoma.